UnitedHealth (UNH): A Data Giant Hidden in an Insurer's Crisis Investment Narrative – February 2026 Price Target (12m): $395.00 (+35% upside) Rating: Strong Buy (Contrarian) 1. The Core Thesis: The "Optum" Mispricing The market is currently valuing UnitedHealth through the narrow lens of a traditional insurer struggling with Medicare Advantage (MA) rate cuts and CMS regulatory headwinds for 2027.Read more

BQE Water helps mining companies clean and manage their water, and demand for its specialized services is rising fast as more projects come in. The catch is the market still prices it like a slow, ordinary business, even as it builds a pipeline toward longer-term operating contracts and adds new scientific capabilities.Read more

GCI Liberty controls a telecom business in Alaska that throws off steady cash, but the market still treats it like a problem child after its spin-off. The bigger twist is John Malone’s plan to use a valuable tax shield and potential deal-making to unlock value—while new rivals and policy reliance could still derail the story.Read more

Addus HomeCare benefits from the growing need for in-home care as more Americans age, and it’s using a strong balance sheet to expand through deals and improve how it runs day to day. But the business also depends heavily on government funding and a tight labor market, so even small policy or cost shifts could hit results when expectations are already high.Read more

National HealthCare runs a mix of senior care services and owns much of the property it operates, which helps it stay steady while demand rises as the population ages. The market appears to be punishing the company for a temporary dip in profits, and a smooth rollout of recent buyouts could change how investors view it.Read more